Please check your internet connection and try again.
# Walethmade bromide
## Overview
**Note:** There is no FDA-approved medication known as "Walethmade bromide." It is highly probable this is a misspelling. If you are referring to **Aclidinium bromide** (a long-acting muscarinic antagonist used for COPD) or **Pyridostigmine bromide** (used for myasthenia gravis), please verify the generic name. The following information assumes an error in nomenclature.
***
## Primary Indications
* **Assuming Aclidinium bromide:** Maintenance bronchodilator treatment of COPD.
* **Assuming Pyridostigmine bromide:** Symptomatic treatment of myasthenia gravis.
## Adult Dosing
* **Aclidinium bromide:** 400 mcg via inhalation twice daily.
* **Pyridostigmine bromide:** Initial dose 60 mg orally every 3–6 hours. Maintenance range: 60 mg to 1.5 g daily, titrated to response.
## Pediatric Dosing
* **Aclidinium bromide:** Not indicated for pediatric use.
* **Pyridostigmine bromide:** 7 mg/kg/day divided into 5–6 doses. Adjust based on clinical response.
## Dose Adjustments
* **Renal/Hepatic:** No specific adjustments for Aclidinium. For Pyridostigmine, lower doses may be required in renal impairment due to reduced excretion.
## Contraindications
* **Aclidinium bromide:** Hypersensitivity to milk proteins (lactose) or atropine derivatives; acute treatment of bronchospasm.
* **Pyridostigmine bromide:** Mechanical intestinal or urinary obstruction; hypersensitivity.
## Adverse Effects
* **Aclidinium bromide:** Headache, nasopharyngitis, cough, sinusitis.
* **Pyridostigmine bromide:** Cholinergic crisis (excessive salivation, bradycardia, diarrhea, muscle fasciculations, abdominal cramps).
## Key Drug Interactions
* **Aclidinium bromide:** Concurrent use with other anticholinergics (additive effects).
* **Pyridostigmine bromide:** Beta-blockers (increased risk of bradycardia); succinylcholine (prolonged neuromuscular blockade); aminoglycosides (may antagonize therapeutic effect).
## Monitoring
* **Aclidinium bromide:** Monitor for paradoxical bronchospasm and worsening of narrow-angle glaucoma or urinary retention.
* **Pyridostigmine bromide:** Monitor for signs of cholinergic vs. myasthenic crisis; monitor heart rate and respiratory status.
## Clinical Pearls
* **Verification Required:** The term "Walethmade" does not exist in standard pharmacological databases (e.g., Lexicomp, Micromedex). Determine if the intended drug was a misinterpreted brand name or a different chemical entity.
* **Safety Warning:** Never administer a medication based on an unverified or ambiguous drug name. Confirm the exact spelling with the ordering provider or the original prescription source.
***
**Educational Disclaimer:** This information is provided for educational purposes only. Always verify drug names, dosing, and clinical appropriateness through official local pharmacy protocols, official product labeling (package inserts), or institutional clinical decision support systems before administration.
